YorkBridge Wealth Partners’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$318K	Sell	1,461 -173	-11%	-$37.8K	0.08%	175
2022 Q3	$322K	Buy	1,634 +199	+14%	+$43K	0.08%	178
2022 Q2	$307K	Buy	1,435 +268	+23%	+$65.5K	0.08%	186
2022 Q1	$331K	Sell	1,167 -24	-2%	-$7.4K	0.07%	216
2021 Q4	$449K	Buy	1,191 +26	+2%	+$10.1K	0.1%	161
2021 Q3	$481K	Sell	1,165 -80	-6%	-$33.2K	0.12%	135
2021 Q2	$461K	Sell	1,245 -57	-4%	-$19K	0.12%	133
2021 Q1	$377K	Buy	1,302 +281	+28%	+$78.1K	0.11%	150
2020 Q4	$255K	Sell	1,021 -15	-1%	-$3.57K	0.09%	169
2020 Q3	$235K	Buy	+1,036	New	+$215K	0.1%	158
2019 Q3	–	Sell	-1,252	Closed	-$178K	–	269
2019 Q2	$178K	Sell	1,252 -11	-0.9%	-$1.49K	0.08%	182
2019 Q1	$183K	Buy	1,263 +12	+1%	+$1.58K	0.08%	172
2018 Q4	$142K	Sell	1,251 -33	-3%	-$4.13K	0.08%	189
2018 Q3	$171K	Sell	1,284 -10	-0.8%	-$1.23K	0.08%	188
2018 Q2	$145K	Buy	1,294 +44	+4%	+$4.76K	0.06%	221
2018 Q1	$133K	Buy	1,250 +81	+7%	+$8.73K	0.06%	237
2017 Q4	$117K	Buy	1,169 +78	+7%	+$8.49K	0.06%	258
2017 Q3	$118K	Buy	1,091 +891	+446%	+$91.5K	0.06%	239
2017 Q2	$20K	Hold	200	–	–	0.01%	510
2017 Q1	$18K	Hold	200	–	–	0.01%	529
2016 Q4	$14K	Buy	+200	New	+$15.2K	0.01%	513